John Rakow - SVP, Genl Counsel, Acting CFO at Adverum Biotechnologies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Genl Counsel, Acting CFO
Stock Symbol
ADVM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John Rakow since 7/7/2023

Holdings reported by John Rakow for Adverum Biotechnologies, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 58,233 $90.2 K $1.55 Jun 3, 2022 Direct
Performance Based Stock Option (Right to Buy) 75,257 Sep 14, 2022 Direct Common Stock
Stock Option (Right to Buy) 42,813 Sep 14, 2022 Direct Common Stock

Transactions reported by John Rakow for Adverum Biotechnologies, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership